I. Redei

发表

Hematopoietic cell transplantation with cord blood for cure of HIV infections.

J. Kurtzberg, E. Shpall, J. Rossi, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation.

S. Lonial, M. Boyer, E. Waller, 2001, Blood.

Hematopoietic Cell Transplantation in Diffuse Large B‐cell Lymphoma

I. Redei, S. Abutalib, 2014 .

Larger numbers of CD4bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation

S. Lonial, M. Boyer, E. Waller, 2001 .

Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation

S. Dix, H. Holland, I. Redei, 1997, Bone Marrow Transplantation.

Rapid hematopoietic engraftment following fractionated TBI conditioning and transplantation with CD34+ enriched hematopoietic progenitor cells from partially mismatched related donors

S. Lonial, I. Redei, E. Hamilton, 2002, Bone Marrow Transplantation.

Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas

P. Engstrom, P. O'dwyer, K. Amfoh, 1995, Investigational New Drugs.

A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.

S. Lonial, C. Torre, E. Waller, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Larger numbers of CD 4 bright dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation

S. Lonial, M. Boyer, E. Waller, 2001 .

Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.

S. Lonial, A. Caliendo, E. Waller, 2002, Blood.

Phase II trial of PALA and 6-methylmercaptopurine riboside (MMPR) in combination with 5-fluorouracil in advanced pancreatic cancer

L. Weiner, P. O'dwyer, J. Hoffman, 2004, Investigational New Drugs.

Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.

S. Lonial, E. Waller, A. Langston, 2004, Blood cells, molecules & diseases.

Acanthamoeba castellani encephalitis following partially mismatched related donor peripheral stem cell transplantation

F. Nolte, G. Visvesvara, A. Castellano-Sanchez, 2003, Transplant infectious disease : an official journal of the Transplantation Society.

Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation.

S. Lonial, E. Waller, A. Langston, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful engraftment after primary graft failure in aplastic anemia using G-CSF mobilized peripheral stem cell transfusions

H. Holland, I. Redei, J. Wingard, 1997, Bone Marrow Transplantation.

Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile.

S. Goldberg, A. Rao, I. Redei, 1996, Bone marrow transplantation.

Maintenance therapy with thalidomide improves overall survival after autologous hematopoietic progenitor cell transplantation for multiple myeloma

S. Lonial, E. Waller, A. Langston, 2006, Cancer.